Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.60 |
| ▸ | MEN1 | O00255 | 5/20 | 0.60 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.56 |
| ▸ | GAA | P10253 | 5/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | NPC1 | O15118 | 2/20 | 0.55 |
| ▸ | RAB9A | P51151 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | CDC7 | O00311 | 1/20 | 0.50 |
| ▸ | PLK4 | O00444 | 1/20 | 0.50 |
| ▸ | AURKA | O14965 | 1/20 | 0.50 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.50 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.50 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.50 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.50 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30502466 | 0.82 | ALDH1A1 (1.00) | ALDH1A1KMT2AMEN1NOX1KDM4E | |
| SCHEMBL21972579 | 0.77 | ALDH1A1 (0.60) | ALDH1A1KMT2AMEN1NOX1KDM4E | |
| SCHEMBL11822889 | 0.76 | KMT2A (0.53) | ALDH1A1KMT2AMEN1GAARAB9A | |
| SCHEMBL25279561 | 0.72 | RECQL (0.68) | KMT2AMEN1CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL28633748 | 0.72 | NOX1 (0.66) | ALDH1A1KMT2AMEN1NOX1KDM4E | |
| SCHEMBL315308 | 0.71 | PKM (0.60) | ALDH1A1KMT2AMEN1NOX1KDM4E | |
| SCHEMBL14520110 | 0.70 | KMT2A (0.53) | KMT2AMEN1GAARAB9AMAPT | |
| SCHEMBL3808723 | 0.70 | GAA (1.00) | ALDH1A1KMT2AMEN1NOX1KDM4E | |
| SCHEMBL10548838 | 0.70 | CNR1 (0.66) | KMT2AMEN1NPC1RAB9A | |
| SCHEMBL30368438 | 0.69 | SMN1; SMN2 (0.81) | KMT2AMEN1NPC1RAB9AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8492415-B2 | Azoles and related derivatives as non-nucleoside reverse transcriptase inhibitors (NNRTIs) in antiviral therapy (HIV) | YALE UNIVERSITY (US) | 2013-07-23 | — | — | US | disclosed |
| US-20100168190-A1 | Novel azoles and related derivatives as non-nucleoside reverse transcriptase inhibitors (nnrtis) in antiviral therapy (hiv) | YALE UNIVERSITY (US) | 2010-07-01 | — | — | US | disclosed |
| WO-2009005811-A1 | NOVEL AZOLES AND RELATED DERIVATIVES AS NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (NNRTIS) IN ANTIVIRAL THERAPY (HIV) | YALE UNIVERSITY (US) | 2009-01-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100168190-A1 | Novel azoles and related derivatives as non-nucleoside reverse transcriptase inhibitors (nnrtis) in antiviral therapy (hiv) | OXA1L, POLRMT, PNP | ALDH1A1 1409/4885KMT2A 1671/4885MEN1 4760/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.